相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M. P. Morelli et al.
ANNALS OF ONCOLOGY (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
Jeng-Sen Tseng et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
Actionable Mutations in Plasma Cell-Free DNA in Patients with Advanced Cancers Referred for Experimental Targeted Therapies
Filip Janku et al.
ONCOTARGET (2015)
Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
P. Ramos et al.
ONCOGENE (2015)
Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders
David M. Hyman et al.
CANCER DISCOVERY (2015)
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
M. Ignatiadis et al.
ANNALS OF ONCOLOGY (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
The evolution of the unstable cancer genome
Rebecca A. Burrell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer
Christoph Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Analytical Validation of BRAF Mutation Testing from Circulating Free DNA Using the Amplification Refractory Mutation Testing System
Kyaw L. Aung et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma
David J. Panka et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Acquired resistance to EGFR-targeted therapies in colorectal cancer
Beth O. Van Emburgh et al.
MOLECULAR ONCOLOGY (2014)
Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Simona Soverini et al.
LEUKEMIA RESEARCH (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Alain R. Thierry et al.
NATURE MEDICINE (2014)
Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
Zhijie Wang et al.
PLOS ONE (2014)
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
Filip Janku et al.
ONCOTARGET (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing
David Wong et al.
CLINICAL BIOCHEMISTRY (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
Ioanna Balgkouranidou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
Feng-Kai Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Diego M. Marzese et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
Nicola Normanno et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Circulating BRAFV600E in the Diagnosis and Follow-Up of Differentiated Papillary Thyroid Carcinoma
C. Pupilli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
Anneli Dowler Nygaard et al.
LUNG CANCER (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis
Paola Ulivi et al.
PLOS ONE (2013)
Non-invasive prenatal testing for aneuploidy: current status and future prospects
P. Benn et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2013)
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Ellen Heitzer et al.
GENOME MEDICINE (2013)
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
Jan Dominik Kuhlmann et al.
BMC CANCER (2012)
Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury
Hada Macher et al.
CLINICA CHIMICA ACTA (2012)
Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2012)
Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Karen-Lise Garm Spindler et al.
CLINICAL CANCER RESEARCH (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
The value of serial plasma nuclear and mitochondrial DNA levels in acute spontaneous intra-cerebral haemorrhage
H. -C. Wang et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Transformation of non-tumor host cells during tumor progression: theories and evidence
Dolores C. Garcia-Olmo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Prognostic role of methylated free circulating DNA in colorectal cancer
Alexander B. Philipp et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
D. Hashad et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer
Kang-Yi Su et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients
Noriko Fujita et al.
ONCOLOGY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
Georg Goebel et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke
Nai-Wen Tsai et al.
CLINICA CHIMICA ACTA (2011)
A sensitive method to quantify human cell-free circulating DNA in blood: Relevance to myocardial infarction screening
Rong-Rong Jing et al.
CLINICAL BIOCHEMISTRY (2011)
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Kazuya Taniguchi et al.
CLINICAL CANCER RESEARCH (2011)
The inverted pyramid of biomarker-driven trials
Ignacio Garrido-Laguna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Florent Mouliere et al.
PLOS ONE (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
Benoit Lefebure et al.
ANNALS OF SURGERY (2010)
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
Aparna A. Kamat et al.
CANCER (2010)
Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
Dolores C. Garcia-Olmo et al.
CANCER RESEARCH (2010)
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
Shuhang Wang et al.
CLINICAL CANCER RESEARCH (2010)
Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
Elisa Danese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
Gayatri Sharma et al.
LIFE SCIENCES (2010)
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Young Lim Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Alain R. Thierry et al.
NUCLEIC ACIDS RESEARCH (2010)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
Tony K. F. Yung et al.
CLINICAL CANCER RESEARCH (2009)
Fine-needle aspiration (FNA) biopsy: historical aspects
Aristidis Diamantis et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2009)
Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy Controls
Kyong-Ah Yoon et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
Massimiliano Paci et al.
LUNG CANCER (2009)
Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
Zhenbin Chen et al.
PLOS ONE (2009)
A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids
Hagit Goldshtein et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
The origin of elevated levels of circulating DNA in blood plasma of premature neonates
N. O. Tnaeva et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer
Heidi Schwarzenbach et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
M. Frattini et al.
CANCER LETTERS (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer
Raquel Catarino et al.
DNA AND CELL BIOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors
Rebecca R. Zachariah et al.
OBSTETRICS AND GYNECOLOGY (2008)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Free circulating DNA as possible tumour marker in colorectal cancer
L. Boni et al.
SURGICAL ONCOLOGY-OXFORD (2007)
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy
Masaru Shinozaki et al.
CLINICAL CANCER RESEARCH (2007)
Circulating nucleic acids (CNAs) and cancer - A survey
M. Fleischhacker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers
JY Wang et al.
WORLD JOURNAL OF SURGERY (2004)
Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome
A Fujimoto et al.
CANCER RESEARCH (2004)
The use of fluorometric assays to assess the immune response to DNA in murine systemic lupus erythematosus
L Björkman et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Degradation of chromosomal DNA during apoptosis
S Nagata et al.
CELL DEATH AND DIFFERENTIATION (2003)
分享论文
